arrow
B

Balázs Ács

karolinska institutet
H指数:29
被引数:4,013

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助palbociclib联合内分泌治疗与化疗在ER+/HER2-乳腺癌中的比较:一项随机II期试验

2026-04-080
OAAI
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma

理解TILs: 胃食管癌中肿瘤浸润淋巴细胞形态学评估的建议

2026-02-050
OAAI
Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study

帕博利珠单抗为基础的新辅助治疗在ER低表达与ER零表达乳腺癌中的病理学反应:一项瑞典基于人群的队列研究

2025-11-290
OAAI
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study

乳腺癌患者接受阿贝西利或瑞博西利辅助治疗的患病率与预后:一项全国性基于人群的研究

2025-09-290
OAAI
Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data

计算病理学注释增强了乳腺癌空间转录组学数据的分辨率和解释。

2025-09-090
OAAI
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images

揭示模型不可知的多尺度分析的力量,以增强乳腺癌组织病理学图像中的人工智能模型

2024-09-010
OA
Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images
2024-03-266
OAAI
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
2024-03-034
PRE